Crossmark

Systemic inflammatory indices as accessible biomarkers for intracranial outcome and prognosis in driver gene-negative NSCLC with brain metastases treated with first-line chemoimmunotherapy

Crossref DOI link: https://doi.org/10.1007/s12672-026-05042-9

Published Online: 2026-04-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tang, Mengqiu

Chen, Tian

Wang, Peijin

Li, Shiwei

He, Jinxian

Zhou, Yang
Funding

Funding for this research was provided by:

Zhejiang Medical and Health Science and Technology Plan Project (2025KY1302)

Natural Science Foundation of Ningbo (2023J031)

National Natural Science Foundation of China (12575364)

Huili Medical and Health Science and Technology Plan Project (2025ZDY001)
License Information

Text and Data Mining valid from 2026-04-29

Accepted Manuscript valid from 2026-04-29
More Information

Article History

Received: 14 January 2026

Accepted: 15 April 2026

First Online: 29 April 2026

Declarations

:

: This study was conducted in accordance with the principles of the Declaration of Helsinki. The Ethics Committee of Ningbo Medical Center Lihuili Hospital approved the study protocol (approval number: KY2025SL411-01). As this was a retrospective review, patient names and other identifying information were anonymized or maintained confidentially.

: All authors have read this manuscript and agree to publish.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below